Pharmaceutical Preparations · NV · CIK 1583648
Develops and commercializes novel therapies for rare skin diseases and vascular malformations
Comparable business profile · signals at a glance
In the 90 days to Mar 18, 2026: 2 insiders bought $800K · 1 sold $1.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 18, 2026 | Goin KathleenChief Operating Officer | Sell | 2,268 | $117.56 | $267K |
| Mar 18, 2026 | Goin KathleenChief Operating Officer | Sell | 1,730 | $118.37 | $205K |
| Mar 18, 2026 | Goin KathleenChief Operating Officer | Sell | 304 | $119.08 | $36K |
| Feb 27, 2026 | Jenkins George MDirector | Buy | 4,000 | $125.00 | $500K |
| Feb 27, 2026 | Heron Elaine JDirector | Buy | 2,400 | $125.00 | $300K |
| Feb 18, 2026 | Goin KathleenChief Operating Officer | Sell | 3,026 | $79.16 | $240K |
| Feb 18, 2026 | Goin KathleenChief Operating Officer | Sell | 1,276 | $79.97 | $102K |
| Jan 21, 2026 | Goin KathleenChief Operating Officer | Sell | 3,749 | $97.94 | $367K |
| Jan 21, 2026 | Goin KathleenChief Operating Officer | Sell | 553 | $95.49 | $53K |
| Dec 17, 2025 | Goin KathleenChief Operating Officer | Sell | 4,302 | $96.47 | $415K |
| Nov 19, 2025 | Goin KathleenChief Operating Officer | Sell | 2,802 | $86.51 | $242K |
| Nov 19, 2025 | Goin KathleenChief Operating Officer | Sell | 1,500 | $85.72 | $129K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.